Vnitr Lek 2022, 68(6):408-409 | DOI: 10.36290/vnl.2022.083

What is the goal blood pressure in kidney transplant recipients?

Tomáš Roháľ
Klinika nefrologie, Transplantcentrum, IKEM, Praha

Arterial hypertension is a frequent condition after kidney transplantation and its treatment is a common agenda of the follow-up care. Retrospective data show that treatment of arterial hypertension decreases the risk of kidney graft loss. While randomized controlled trials for target blood pressures in kidney transplant recipients are not available, < 130/80 mm Hg is the most frequently mentioned value. Generally, all classes of antihypertensive drugs can be used, but it is important to consider timing after transplantation and possible interactions with immunosuppressive drugs.

Keywords: arterial hypertension, guidelines, KDIGO, kidney transplantation.

Accepted: September 23, 2022; Published: October 3, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Roháľ T. What is the goal blood pressure in kidney transplant recipients? Vnitr Lek. 2022;68(6):408-409. doi: 10.36290/vnl.2022.083.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. U.S. Renal Data System. USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End‑Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2010. Dostupné z WWW: .
    2. Vella J, Brennan DC. Kidney transplantation in adults: Hypertension after kidney transplantation. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. https://www.uptodate.com. (cit. 2022-04-24).
    3. Margreiter R. Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: A randomised multicentre study. Lancet. 2002;359(9308):741-746. Go to original source... Go to PubMed...
    4. Paoletti E, Gherzi M, Amidone M et al. Association of arterial hypertension with renal target organ damage in kidney transplant recipients: The predictive role of ambulatory blood pressure monitoring. Transplantation. 2009;87(12):1864-1869. Go to original source... Go to PubMed...
    5. Tantisattamo E, Molnar MZ, Ho BT et al. Approach and Management of Hypertension After Kidney Transplantation. Front Med. 2020;7:229. Go to original source... Go to PubMed...
    6. Opelz G, Wujciak T, Ritz E. Association of chronic kidney graft failure with recipient blood pressure. Kidney Int. 1998;53(1):217-222. Go to original source... Go to PubMed...
    7. Kasiske BL, Anjum S, Shah R et al. Hypertension after kidney transplantation. Am J Kidney, DiS. 2004;43(6):1071-1081. Go to original source... Go to PubMed...
    8. Opelz G, Dohler B. Improved Long‑Term Outcomes After Renal Transplantation Associated with Blood Pressure Control. Am J Transplant. 2005;5(11):2725-2731. Go to original source... Go to PubMed...
    9. Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int. 2021;99(3S):S1-S87. Go to original source... Go to PubMed...
    10. SPRINT Research Group, Wright JT, Williamson JD, et al. A Randomized Trial of Intensive versus Standard Blood‑Pressure Control. N Engl J Med. 2015;373(22):2103-2116. Go to original source... Go to PubMed...
    11. Widimský J Jr., Filipovský J, Ceral J et al. Doporučení pro diagnostiku a léčbu arteriální hypertenze ČSH 2017. Hypertenze & kardiovaskulární prevence. 2018; (Supplementum).
    12. Cross NB, Webster AC, Masson P et al. Antihypertensive treatment for kidney transplant recipients. Cochrane Database Syst Rev. 2009;(3): CD003598. Go to original source...

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.